EXPERT OPINION ON THERAPEUTIC TARGETS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2108886, encodeId=fa2b2108886ba, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：靶向纳米制剂 经验分享：审稿真的非常慢，可能是我文章的问题，4个月才返回小修意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b766536385, createdName=ms9000002020094343, createdTime=Thu Jan 05 09:39:45 CST 2023, time=2023-01-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1090475, encodeId=43fa10904e5fc, content=如何申请延期？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090476, encodeId=34c410904e682, content=如何写延期信？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574759, encodeId=17395e4759d9, content=审稿周期慢，每次催稿都是敷衍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79ea76615, createdName=fg5001, createdTime=Tue Aug 13 22:07:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568718, encodeId=82a8568e18e5, content=投稿命中率:25.0 经验分享：确实很难，刷新了我对拒稿速度的认知水平。投了一篇，投稿成功邮件和拒稿邮件是同时收到的。时间显示前后仅相差4分钟。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eab21323896, createdName=442531979, createdTime=Thu Mar 28 00:00:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544005, encodeId=b81c544005d7, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521337, encodeId=f78252133e5e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一篇文章在这个杂志发表了，属于一投就中，幸运之极。主要是文章和杂志的收稿很对胃口，中间修回一次要求添加siRNA，增加文章的说服力，时间比较紧张，后来要求编辑延长修改时间才搞定。编辑很nice，文章一旦接受后，见刊的时间很快，而且如果时间不急的话可以考虑Standard模式，不要版面费。很划算！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a92872, createdName=ethan411, createdTime=Fri Apr 15 10:33:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511856, encodeId=15ca511856d3, content=12年中了一篇，现在再投一篇综述，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/21/bf5cdbadd9e7120cd32848fdaacc42c2.jpg, createdBy=d9ef104615, createdName=mammarist, createdTime=Wed May 13 22:20:00 CST 2015, time=2015-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494823, encodeId=f681494823e7, content=希望2012年IF>4.本人近期在该刊物上发了一篇，主要侧重一些药物的临床试药中的一些新的效果。还是有一定的难度。我的这篇文章周期大概是5个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 03 16:00:00 CST 2013, time=2013-04-03, status=1, ipAttribution=)]

2023-01-05 ms9000002020094343 来自重庆

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：靶向纳米制剂
经验分享：审稿真的非常慢，可能是我文章的问题，4个月才返回小修意见

68 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2108886, encodeId=fa2b2108886ba, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：靶向纳米制剂 经验分享：审稿真的非常慢，可能是我文章的问题，4个月才返回小修意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b766536385, createdName=ms9000002020094343, createdTime=Thu Jan 05 09:39:45 CST 2023, time=2023-01-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1090475, encodeId=43fa10904e5fc, content=如何申请延期？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090476, encodeId=34c410904e682, content=如何写延期信？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574759, encodeId=17395e4759d9, content=审稿周期慢，每次催稿都是敷衍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79ea76615, createdName=fg5001, createdTime=Tue Aug 13 22:07:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568718, encodeId=82a8568e18e5, content=投稿命中率:25.0 经验分享：确实很难，刷新了我对拒稿速度的认知水平。投了一篇，投稿成功邮件和拒稿邮件是同时收到的。时间显示前后仅相差4分钟。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eab21323896, createdName=442531979, createdTime=Thu Mar 28 00:00:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544005, encodeId=b81c544005d7, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521337, encodeId=f78252133e5e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一篇文章在这个杂志发表了，属于一投就中，幸运之极。主要是文章和杂志的收稿很对胃口，中间修回一次要求添加siRNA，增加文章的说服力，时间比较紧张，后来要求编辑延长修改时间才搞定。编辑很nice，文章一旦接受后，见刊的时间很快，而且如果时间不急的话可以考虑Standard模式，不要版面费。很划算！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a92872, createdName=ethan411, createdTime=Fri Apr 15 10:33:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511856, encodeId=15ca511856d3, content=12年中了一篇，现在再投一篇综述，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/21/bf5cdbadd9e7120cd32848fdaacc42c2.jpg, createdBy=d9ef104615, createdName=mammarist, createdTime=Wed May 13 22:20:00 CST 2015, time=2015-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494823, encodeId=f681494823e7, content=希望2012年IF>4.本人近期在该刊物上发了一篇，主要侧重一些药物的临床试药中的一些新的效果。还是有一定的难度。我的这篇文章周期大概是5个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 03 16:00:00 CST 2013, time=2013-04-03, status=1, ipAttribution=)]

2021-12-28 Mia

如何申请延期？

88 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2108886, encodeId=fa2b2108886ba, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：靶向纳米制剂 经验分享：审稿真的非常慢，可能是我文章的问题，4个月才返回小修意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b766536385, createdName=ms9000002020094343, createdTime=Thu Jan 05 09:39:45 CST 2023, time=2023-01-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1090475, encodeId=43fa10904e5fc, content=如何申请延期？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090476, encodeId=34c410904e682, content=如何写延期信？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574759, encodeId=17395e4759d9, content=审稿周期慢，每次催稿都是敷衍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79ea76615, createdName=fg5001, createdTime=Tue Aug 13 22:07:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568718, encodeId=82a8568e18e5, content=投稿命中率:25.0 经验分享：确实很难，刷新了我对拒稿速度的认知水平。投了一篇，投稿成功邮件和拒稿邮件是同时收到的。时间显示前后仅相差4分钟。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eab21323896, createdName=442531979, createdTime=Thu Mar 28 00:00:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544005, encodeId=b81c544005d7, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521337, encodeId=f78252133e5e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一篇文章在这个杂志发表了，属于一投就中，幸运之极。主要是文章和杂志的收稿很对胃口，中间修回一次要求添加siRNA，增加文章的说服力，时间比较紧张，后来要求编辑延长修改时间才搞定。编辑很nice，文章一旦接受后，见刊的时间很快，而且如果时间不急的话可以考虑Standard模式，不要版面费。很划算！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a92872, createdName=ethan411, createdTime=Fri Apr 15 10:33:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511856, encodeId=15ca511856d3, content=12年中了一篇，现在再投一篇综述，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/21/bf5cdbadd9e7120cd32848fdaacc42c2.jpg, createdBy=d9ef104615, createdName=mammarist, createdTime=Wed May 13 22:20:00 CST 2015, time=2015-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494823, encodeId=f681494823e7, content=希望2012年IF>4.本人近期在该刊物上发了一篇，主要侧重一些药物的临床试药中的一些新的效果。还是有一定的难度。我的这篇文章周期大概是5个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 03 16:00:00 CST 2013, time=2013-04-03, status=1, ipAttribution=)]

2021-12-27 rayms

如何写延期信？

78 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2108886, encodeId=fa2b2108886ba, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：靶向纳米制剂 经验分享：审稿真的非常慢，可能是我文章的问题，4个月才返回小修意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b766536385, createdName=ms9000002020094343, createdTime=Thu Jan 05 09:39:45 CST 2023, time=2023-01-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1090475, encodeId=43fa10904e5fc, content=如何申请延期？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090476, encodeId=34c410904e682, content=如何写延期信？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574759, encodeId=17395e4759d9, content=审稿周期慢，每次催稿都是敷衍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79ea76615, createdName=fg5001, createdTime=Tue Aug 13 22:07:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568718, encodeId=82a8568e18e5, content=投稿命中率:25.0 经验分享：确实很难，刷新了我对拒稿速度的认知水平。投了一篇，投稿成功邮件和拒稿邮件是同时收到的。时间显示前后仅相差4分钟。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eab21323896, createdName=442531979, createdTime=Thu Mar 28 00:00:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544005, encodeId=b81c544005d7, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521337, encodeId=f78252133e5e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一篇文章在这个杂志发表了，属于一投就中，幸运之极。主要是文章和杂志的收稿很对胃口，中间修回一次要求添加siRNA，增加文章的说服力，时间比较紧张，后来要求编辑延长修改时间才搞定。编辑很nice，文章一旦接受后，见刊的时间很快，而且如果时间不急的话可以考虑Standard模式，不要版面费。很划算！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a92872, createdName=ethan411, createdTime=Fri Apr 15 10:33:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511856, encodeId=15ca511856d3, content=12年中了一篇，现在再投一篇综述，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/21/bf5cdbadd9e7120cd32848fdaacc42c2.jpg, createdBy=d9ef104615, createdName=mammarist, createdTime=Wed May 13 22:20:00 CST 2015, time=2015-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494823, encodeId=f681494823e7, content=希望2012年IF>4.本人近期在该刊物上发了一篇，主要侧重一些药物的临床试药中的一些新的效果。还是有一定的难度。我的这篇文章周期大概是5个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 03 16:00:00 CST 2013, time=2013-04-03, status=1, ipAttribution=)]

2019-08-13 fg5001

审稿周期慢，每次催稿都是敷衍

172 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2108886, encodeId=fa2b2108886ba, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：靶向纳米制剂 经验分享：审稿真的非常慢，可能是我文章的问题，4个月才返回小修意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b766536385, createdName=ms9000002020094343, createdTime=Thu Jan 05 09:39:45 CST 2023, time=2023-01-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1090475, encodeId=43fa10904e5fc, content=如何申请延期？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090476, encodeId=34c410904e682, content=如何写延期信？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574759, encodeId=17395e4759d9, content=审稿周期慢，每次催稿都是敷衍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79ea76615, createdName=fg5001, createdTime=Tue Aug 13 22:07:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568718, encodeId=82a8568e18e5, content=投稿命中率:25.0 经验分享：确实很难，刷新了我对拒稿速度的认知水平。投了一篇，投稿成功邮件和拒稿邮件是同时收到的。时间显示前后仅相差4分钟。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eab21323896, createdName=442531979, createdTime=Thu Mar 28 00:00:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544005, encodeId=b81c544005d7, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521337, encodeId=f78252133e5e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一篇文章在这个杂志发表了，属于一投就中，幸运之极。主要是文章和杂志的收稿很对胃口，中间修回一次要求添加siRNA，增加文章的说服力，时间比较紧张，后来要求编辑延长修改时间才搞定。编辑很nice，文章一旦接受后，见刊的时间很快，而且如果时间不急的话可以考虑Standard模式，不要版面费。很划算！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a92872, createdName=ethan411, createdTime=Fri Apr 15 10:33:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511856, encodeId=15ca511856d3, content=12年中了一篇，现在再投一篇综述，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/21/bf5cdbadd9e7120cd32848fdaacc42c2.jpg, createdBy=d9ef104615, createdName=mammarist, createdTime=Wed May 13 22:20:00 CST 2015, time=2015-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494823, encodeId=f681494823e7, content=希望2012年IF>4.本人近期在该刊物上发了一篇，主要侧重一些药物的临床试药中的一些新的效果。还是有一定的难度。我的这篇文章周期大概是5个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 03 16:00:00 CST 2013, time=2013-04-03, status=1, ipAttribution=)]

2019-03-28 442531979

投稿命中率:25.0
经验分享：确实很难，刷新了我对拒稿速度的认知水平。投了一篇，投稿成功邮件和拒稿邮件是同时收到的。时间显示前后仅相差4分钟。

196 0

[GetPortalCommentsPageByObjectIdResponse(id=2108886, encodeId=fa2b2108886ba, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：靶向纳米制剂 经验分享：审稿真的非常慢，可能是我文章的问题，4个月才返回小修意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b766536385, createdName=ms9000002020094343, createdTime=Thu Jan 05 09:39:45 CST 2023, time=2023-01-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1090475, encodeId=43fa10904e5fc, content=如何申请延期？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090476, encodeId=34c410904e682, content=如何写延期信？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574759, encodeId=17395e4759d9, content=审稿周期慢，每次催稿都是敷衍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79ea76615, createdName=fg5001, createdTime=Tue Aug 13 22:07:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568718, encodeId=82a8568e18e5, content=投稿命中率:25.0 经验分享：确实很难，刷新了我对拒稿速度的认知水平。投了一篇，投稿成功邮件和拒稿邮件是同时收到的。时间显示前后仅相差4分钟。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eab21323896, createdName=442531979, createdTime=Thu Mar 28 00:00:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544005, encodeId=b81c544005d7, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521337, encodeId=f78252133e5e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一篇文章在这个杂志发表了，属于一投就中，幸运之极。主要是文章和杂志的收稿很对胃口，中间修回一次要求添加siRNA，增加文章的说服力，时间比较紧张，后来要求编辑延长修改时间才搞定。编辑很nice，文章一旦接受后，见刊的时间很快，而且如果时间不急的话可以考虑Standard模式，不要版面费。很划算！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a92872, createdName=ethan411, createdTime=Fri Apr 15 10:33:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511856, encodeId=15ca511856d3, content=12年中了一篇，现在再投一篇综述，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/21/bf5cdbadd9e7120cd32848fdaacc42c2.jpg, createdBy=d9ef104615, createdName=mammarist, createdTime=Wed May 13 22:20:00 CST 2015, time=2015-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494823, encodeId=f681494823e7, content=希望2012年IF>4.本人近期在该刊物上发了一篇，主要侧重一些药物的临床试药中的一些新的效果。还是有一定的难度。我的这篇文章周期大概是5个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 03 16:00:00 CST 2013, time=2013-04-03, status=1, ipAttribution=)]

2017-07-16 wang_di98

徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了

344 0

[GetPortalCommentsPageByObjectIdResponse(id=2108886, encodeId=fa2b2108886ba, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：靶向纳米制剂 经验分享：审稿真的非常慢，可能是我文章的问题，4个月才返回小修意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b766536385, createdName=ms9000002020094343, createdTime=Thu Jan 05 09:39:45 CST 2023, time=2023-01-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1090475, encodeId=43fa10904e5fc, content=如何申请延期？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090476, encodeId=34c410904e682, content=如何写延期信？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574759, encodeId=17395e4759d9, content=审稿周期慢，每次催稿都是敷衍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79ea76615, createdName=fg5001, createdTime=Tue Aug 13 22:07:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568718, encodeId=82a8568e18e5, content=投稿命中率:25.0 经验分享：确实很难，刷新了我对拒稿速度的认知水平。投了一篇，投稿成功邮件和拒稿邮件是同时收到的。时间显示前后仅相差4分钟。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eab21323896, createdName=442531979, createdTime=Thu Mar 28 00:00:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544005, encodeId=b81c544005d7, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521337, encodeId=f78252133e5e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一篇文章在这个杂志发表了，属于一投就中，幸运之极。主要是文章和杂志的收稿很对胃口，中间修回一次要求添加siRNA，增加文章的说服力，时间比较紧张，后来要求编辑延长修改时间才搞定。编辑很nice，文章一旦接受后，见刊的时间很快，而且如果时间不急的话可以考虑Standard模式，不要版面费。很划算！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a92872, createdName=ethan411, createdTime=Fri Apr 15 10:33:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511856, encodeId=15ca511856d3, content=12年中了一篇，现在再投一篇综述，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/21/bf5cdbadd9e7120cd32848fdaacc42c2.jpg, createdBy=d9ef104615, createdName=mammarist, createdTime=Wed May 13 22:20:00 CST 2015, time=2015-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494823, encodeId=f681494823e7, content=希望2012年IF>4.本人近期在该刊物上发了一篇，主要侧重一些药物的临床试药中的一些新的效果。还是有一定的难度。我的这篇文章周期大概是5个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 03 16:00:00 CST 2013, time=2013-04-03, status=1, ipAttribution=)]

2016-04-15 ethan411

审稿速度:2.0 | 投稿命中率:50.0
经验分享：一篇文章在这个杂志发表了，属于一投就中，幸运之极。主要是文章和杂志的收稿很对胃口，中间修回一次要求添加siRNA，增加文章的说服力，时间比较紧张，后来要求编辑延长修改时间才搞定。编辑很nice，文章一旦接受后，见刊的时间很快，而且如果时间不急的话可以考虑Standard模式，不要版面费。很划算！

335 0

[GetPortalCommentsPageByObjectIdResponse(id=2108886, encodeId=fa2b2108886ba, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：靶向纳米制剂 经验分享：审稿真的非常慢，可能是我文章的问题，4个月才返回小修意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b766536385, createdName=ms9000002020094343, createdTime=Thu Jan 05 09:39:45 CST 2023, time=2023-01-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1090475, encodeId=43fa10904e5fc, content=如何申请延期？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090476, encodeId=34c410904e682, content=如何写延期信？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574759, encodeId=17395e4759d9, content=审稿周期慢，每次催稿都是敷衍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79ea76615, createdName=fg5001, createdTime=Tue Aug 13 22:07:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568718, encodeId=82a8568e18e5, content=投稿命中率:25.0 经验分享：确实很难，刷新了我对拒稿速度的认知水平。投了一篇，投稿成功邮件和拒稿邮件是同时收到的。时间显示前后仅相差4分钟。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eab21323896, createdName=442531979, createdTime=Thu Mar 28 00:00:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544005, encodeId=b81c544005d7, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521337, encodeId=f78252133e5e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一篇文章在这个杂志发表了，属于一投就中，幸运之极。主要是文章和杂志的收稿很对胃口，中间修回一次要求添加siRNA，增加文章的说服力，时间比较紧张，后来要求编辑延长修改时间才搞定。编辑很nice，文章一旦接受后，见刊的时间很快，而且如果时间不急的话可以考虑Standard模式，不要版面费。很划算！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a92872, createdName=ethan411, createdTime=Fri Apr 15 10:33:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511856, encodeId=15ca511856d3, content=12年中了一篇，现在再投一篇综述，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/21/bf5cdbadd9e7120cd32848fdaacc42c2.jpg, createdBy=d9ef104615, createdName=mammarist, createdTime=Wed May 13 22:20:00 CST 2015, time=2015-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494823, encodeId=f681494823e7, content=希望2012年IF>4.本人近期在该刊物上发了一篇，主要侧重一些药物的临床试药中的一些新的效果。还是有一定的难度。我的这篇文章周期大概是5个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 03 16:00:00 CST 2013, time=2013-04-03, status=1, ipAttribution=)]

2015-05-13 mammarist

12年中了一篇，现在再投一篇综述，希望好运

447 0

[GetPortalCommentsPageByObjectIdResponse(id=2108886, encodeId=fa2b2108886ba, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：靶向纳米制剂 经验分享：审稿真的非常慢，可能是我文章的问题，4个月才返回小修意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b766536385, createdName=ms9000002020094343, createdTime=Thu Jan 05 09:39:45 CST 2023, time=2023-01-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1090475, encodeId=43fa10904e5fc, content=如何申请延期？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090476, encodeId=34c410904e682, content=如何写延期信？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574759, encodeId=17395e4759d9, content=审稿周期慢，每次催稿都是敷衍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79ea76615, createdName=fg5001, createdTime=Tue Aug 13 22:07:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568718, encodeId=82a8568e18e5, content=投稿命中率:25.0 经验分享：确实很难，刷新了我对拒稿速度的认知水平。投了一篇，投稿成功邮件和拒稿邮件是同时收到的。时间显示前后仅相差4分钟。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eab21323896, createdName=442531979, createdTime=Thu Mar 28 00:00:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544005, encodeId=b81c544005d7, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521337, encodeId=f78252133e5e, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：一篇文章在这个杂志发表了，属于一投就中，幸运之极。主要是文章和杂志的收稿很对胃口，中间修回一次要求添加siRNA，增加文章的说服力，时间比较紧张，后来要求编辑延长修改时间才搞定。编辑很nice，文章一旦接受后，见刊的时间很快，而且如果时间不急的话可以考虑Standard模式，不要版面费。很划算！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a92872, createdName=ethan411, createdTime=Fri Apr 15 10:33:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511856, encodeId=15ca511856d3, content=12年中了一篇，现在再投一篇综述，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/21/bf5cdbadd9e7120cd32848fdaacc42c2.jpg, createdBy=d9ef104615, createdName=mammarist, createdTime=Wed May 13 22:20:00 CST 2015, time=2015-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494823, encodeId=f681494823e7, content=希望2012年IF>4.本人近期在该刊物上发了一篇，主要侧重一些药物的临床试药中的一些新的效果。还是有一定的难度。我的这篇文章周期大概是5个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 03 16:00:00 CST 2013, time=2013-04-03, status=1, ipAttribution=)]

2013-04-03 匿名用户

希望2012年IF>4.本人近期在该刊物上发了一篇，主要侧重一些药物的临床试药中的一些新的效果。还是有一定的难度。我的这篇文章周期大概是5个月。

422 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务